# Vanda Pharmaceuticals Inc.: Form DEF 14A, filed Apr 23, 2026

- Company: [Vanda Pharmaceuticals Inc.](/companies/vnda.md) (CIK 1347178)
- Form: DEF 14A
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 16:48 ET
- Period: 2026-06-04
- Accession: 0001628280-26-026893
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1347178/000162828026026893/vnda-20260423.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1347178/000162828026026893/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1347178/000162828026026893/vnda-20260423.htm

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-026893. Last ingested by Listed: Oct 29, 2026, 08:08 ET. No prices; not investment advice.